title: Ethical evaluation model for technologies. the role of medical technology in the development of autonomy in diabetes patient.
abstract: Romanian Government Decision (GD) No. 8/2012 amending and supplementing GD No. 144/2010 regarding the function and organization structures of the Ministry of Health defines health technology assessment (HTA) as "a systematic and multidisciplinary analysis of the existing and new medical technologies, through which medical, economic, social, ethical and organizational information are synthesized so that medical technologies to be used in a transparent and unbiased manner". We propose an ethical assessment model of technologies used in the care of diabetic patients. The nature of this research was exploratory, giving the novelty of this approach to the clinical and social context of Romania.
  
  
  METHODS
  The assessment of health technologies used in the care of diabetic patients was based on the following research question: What is the role of health technology in developing autonomy and responsibility in patients suffering from chronic diseases? Individual interviews and focus groups were held from June, 2011 to November, 2012 in Iasi. The criterion for selecting the participants was belonging to the target groups: family doctors or diabetes specialist, patients with type 1 (TID) and type 2 diabetes (T2D), caregivers and other professionals involved in diabetes patient care.
  
  
  BACKGROUND
  The diabetic patient benefits from a specific treatment and has the privilege of self-administering it, his life expectancy and quality of life depending upon the compliance and responsibility he demonstrates.
authors: Center for Ethics and Health Policy, University of Medicine and Pharmacy "Grigore T. Popa", Iasi
authors: Simona
authors: S
authors: Damian
authors: Center for Ethics and Health Policy, University of Medicine and Pharmacy "Grigore T. Popa", Iasi
authors: Roxana
authors: R
authors: Necula
authors: Center for Ethics and Health Policy, University of Medicine and Pharmacy "Grigore T. Popa", Iasi
authors: A
authors: A
authors: Sandu
authors: Center for Ethics and Health Policy, University of Medicine and Pharmacy "Grigore T. Popa", Iasi
authors: Maria Liliana
authors: ML
authors: Iliescu
authors: Center for Ethics and Health Policy, University of Medicine and Pharmacy "Grigore T. Popa", Iasi
authors: Beatrice
authors: B
authors: Ioan
mesh_terms: D015190:Blood Glucose Self-Monitoring / Q000941:ethics / Q000295:instrumentation* / Q000379:methods; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004864:Equipment and Supplies; D017144:Focus Groups; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D017060:Patient Satisfaction; D012383:Romania; D011795:Surveys and Questionnaires; D013673:Technology Assessment, Biomedical / Q000941:ethics / Q000379:methods / Q000458:organization & administration
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin